Next Article in Journal
LDH-A—Modulation and the Variability of LDH Isoenzyme Profiles in Murine Gliomas: A Link with Metabolic and Growth Responses
Next Article in Special Issue
Vestibular Schwannoma Volume and Tumor Growth Correlates with Macrophage Marker Expression
Previous Article in Journal
Cytological Comparison between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Image Analysis Software Using Touch Smear Samples of Surgically Resected Specimens
Previous Article in Special Issue
Primary Skull Base Chondrosarcomas: A Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Microscope-Based Augmented Reality with Intraoperative Computed Tomography-Based Navigation for Resection of Skull Base Meningiomas in Consecutive Series of 39 Patients

1
Department of Neurosurgery, University of Marburg, 35037 Marburg, Germany
2
Marburg Center for Mind, Brain and Behavior (CMBB), 35032 Marburg, Germany
3
Department of Neurosurgery, Helios Dr. Horst Schmidt Kliniken, 65199 Wiesbaden, Germany
*
Author to whom correspondence should be addressed.
Cancers 2022, 14(9), 2302; https://doi.org/10.3390/cancers14092302
Submission received: 1 April 2022 / Revised: 27 April 2022 / Accepted: 4 May 2022 / Published: 6 May 2022
(This article belongs to the Special Issue Skull Base Tumours)

Abstract

:

Simple Summary

The aim of surgery for skull base meningiomas is maximal resection with minimal damage to the involved cranial nerves and cerebral vessels. Compared to non-skull base meningiomas, these lesions show a reduced rate of gross total resection (GTR). Therefore, the use of technologies for improved orientation in the surgical field, such as neuronavigation and augmented reality (AR), is of interest. We confirmed in a consecutive series of 39 patients who underwent surgery for skull base meningiomas that automatic registration with intraoperative computed tomography (iCT) showed high registration accuracy and that microscope-based AR largely facilitated the resection by increasing surgical precision and providing improved intraoperative orientation by visualizing the tumor and the critical neurovascular structures in the operative microscope. No injuries to critical neurovascular structures occurred. There were 26 patients (66.6%) who underwent GTR. Additionally, 33 out of 35 patients who lived to follow-up could ambulate.

Abstract

Background: The aim of surgery for skull base meningiomas is maximal resection with minimal damage to the involved cranial nerves and cerebral vessels; thus, implementation of technologies for improved orientation in the surgical field, such as neuronavigation and augmented reality (AR), is of interest. Methods: Included in the study were 39 consecutive patients (13 male, 26 female, mean age 64.08 ± 13.5 years) who underwent surgery for skull base meningiomas using microscope-based AR and automatic patient registration using intraoperative computed tomography (iCT). Results: Most common were olfactory meningiomas (6), cavernous sinus (6) and clinoidal (6) meningiomas, meningiomas of the medial (5) and lateral (5) sphenoid wing and meningiomas of the sphenoidal plane (5), followed by suprasellar (4), falcine (1) and middle fossa (1) meningiomas. There were 26 patients (66.6%) who underwent gross total resection (GTR) of the meningioma. Automatic registration applying iCT resulted in high accuracy (target registration error, 0.82 ± 0.37 mm). The effective radiation dose of the registration iCT scans was 0.58 ± 1.05 mSv. AR facilitated orientation in the resection of skull base meningiomas with encasement of cerebral vessels and compression of the optic chiasm, as well as in reoperations, increasing surgeon comfort. No injuries to critical neurovascular structures occurred. Out of 35 patients who lived to follow-up, 33 could ambulate at their last presentation. Conclusion: A microscope-based AR facilitates surgical orientation for resection of skull base meningiomas. Registration accuracy is very high using automatic registration with intraoperative imaging.

1. Introduction

In order to minimize the morbidity rate in patients with skull base tumors, integration of preoperative image-based segmentation with three-dimensional (3D) reconstruction of critical neurovascular structures with navigation was proposed [1]. Initial patient registration accuracy is a main factor influencing the overall navigation accuracy, and intraoperative imaging with intraoperative CT (iCT) provides user-independent patient registration [2,3,4]. Microscope-based augmented reality (AR) facilitated by the use of modern microscopes with integrated head-up displays (HUDs) provides visualization of 3D colored objects of interest in real time, which provides additional information and enables improved orientation in the surgical field [5,6]. Application of AR has been integrated into skull base surgery. Microscope-based AR has shown benefits in transsphenoidal surgery for pituitary adenomas and Rathke cysts, especially in cases with anatomic variants and in reoperations [7]. Further applications of AR in skull base surgery include endoscopic-assisted endonasal midline skull base pathologies in adults [8] and children [9], and resections of lesions of the lateral skull base in otorhinolaryngology [10].
Use of AR in resections of meningiomas has been previously described, with a total of 25 cases in the literature, but only 3 of them have been skull base lesions [11,12,13]. A recent case report demonstrated the use of AR for optimization of exposure in clinoid meningioma [13]. Skull base meningiomas are surgically challenging tumors due to the anatomy of the skull base and the proximity of neurovascular structures [14,15]. Thus, the aim of surgery for skull base meningiomas is maximal resection with minimal damage to the involved neurovascular structures [1]. Skull base lesions show a reduced rate of gross total resections compared to non-skull base meningiomas [16]; therefore, implementation of technologies for improved orientation in the surgical field, such as neuronavigation and AR, are needed, as especially cases of recurrent tumors and reoperations are associated with high morbidity and complication rates [15]. To our knowledge, this is the first study to evaluate the use of microscope-based AR for resection in a series of skull base meningiomas.

2. Materials and Methods

Thirty-nine consecutive patients (thirteen male, twenty-six female, mean age 64.08 ± 13.50 years) who underwent surgery for skull base meningiomas at our department by a single surgeon (C.N.) between September 2016 and January 2022 using microscope-based AR and automatic patient registration using iCT were included in the study. The definition of skull base meningiomas was based on Al-Mefty et al. [17]. Indications for surgery included the presence of skull base lesions with neurological deficits, compression of neurovascular structures due to mass effect and presence of lesions primarily suspected of being brain metastases in patients with systemic cancer disease. Written informed consent was provided by all participants and their family members. Ethical approval for prospective archiving of all relevant clinical and technical data with no need for further approval for retrospective analysis was obtained.
The extent of resection was determined on the postoperative MRI 3 months following surgery and was deemed as a gross total resection (GTR) with dural coagulation or removal of adjacent dura and bone (GTR, Simpson Grade I with complete excision including dura and bone, or Grade II with reliable coagulation of the dura attachment [18], subtotal resection (STR) with complete excision but insufficient dural coagulation or bone excision (Simpson Grade III, using a modified classification by Combs et al. with non-visible rest on MRI [19], partial resection (PR, Simpson Grade IV, incomplete excision, but remainder visible on MRI) or open biopsy (Simpson Grade V).

2.1. General Setup

Automatic registration based on iCT without user interaction was performed using a 32-slice movable CT scanner (AIRO, Brainlab, Munich, Germany). Details about the setup, intraoperative CT scanning protocols and conversion factors for determining the effective radiation dose (ED) have been previously described [4].
Segmentation of the tumor was usually performed in the T1-weighted post-contrast MRI modality, manually or using autosegmentation with an anatomical mapping element (Brainlab). Brainlab was used to delineate the optic nerves, chiasm, ventricles, pituitary gland or brain stem with unique colors being assigned to each object, and with additional manual segmentation for correction of the automatic segmentation and for segmentation of tumor and risk structures. For segmentation of the vascular risk structures, contrast-enhanced T1-weighted magnetic resonance imaging (MRI), time-of-flight (TOF) MRI angiography or computed tomography (CT) angiography was used and then rigidly registered. Rigid registration was performed by an image fusion element (Brainlab, Munich, Germany). This 3D data set formed the basis for patient registration [7] (Figure 1).
Head fixation following narcosis and positioning for the appropriate approach was established by applying a radiolucent carbon Doro head clamp. Metallic fixation pins were placed outside the area of the intraoperative scan. The reference array with four reflective markers was attached to the head clamp [4]. Registration scanning was performed following the rotation of the operating table 90° prior to skin incision. Alternatively, registration scanning was performed following craniotomy. The transfer of images was performed automatically by the navigation system, followed by automatic registration with the application of images from the registration iCT scan. Three fiducial markers placed in the scan were of the skin and which were not used for the process of registration, were used to check the accuracy of the automatic registration. For each of the three fiducials, the individual target registration error (TRE) could be measured by placing the tip of the pointer in the divot of the fiducial [4].
Rigid registration of the preoperative plan with the registration CT scan was performed by image fusion software, Brainlab elements (Brainlab, Munich, Germany). Accuracy of the fusion was checked by a spy-glass feature, with visualization of the preoperative images in an insert of the intraoperative CT, which was moved around for detection of registration failure in all views with appropriate anatomical landmarks (Figure 1).

2.2. Augmented Reality

For AR support, the HUDs of the operating microscopes (Pentero 900 (Zeiss, Oberkochen, Germany) or Kinevo 900 (Zeiss, Oberkochen, Germany)) were used. Tracking of the microscope was performed by a registration array attached to the microscope. Checking the calibration of AR was performed by centering the microscope above the divot of the registration array, as well as additional markers. In this way, the optical outline and the AR visualization of the reference array could be adjusted and 3D objects could be visualized in semitransparent, solid or outlined mode using the AR display and the microscope application allowed for visualization of these objects in different modes on the microscope video [7].

3. Results

General characteristics of the patients are summarized in Table 1. Twenty-six patients (66.6%) underwent GTR of the meningioma. The mean surgery time was 300.4 ± 134.1 min. Most common were olfactory meningiomas (n = 6), meningiomas of the cavernous sinus (n = 6) and clinoidal meningiomas (n = 6), meningiomas of the medial (n = 5) and lateral (n = 5) sphenoid wing and meningiomas of the sphenoidal plane (n = 5), followed by suprasellar meningiomas (n = 4), falcine meningioma of anterior fossa (n = 1) and middle and posterior fossa/petrous meningioma (n = 1). Sixteen tumors (41%) had a volume more than 10 cm3 with encasement and compression of the neurovascular structures.
Registration accuracy: Registration scanning was performed prior to skin incision in patients no. 1–29 (n = 28) and following craniotomy in patients no. 29–39 (n = 11). Automatic registration applying intraoperative CT in patients 1–29 resulted in high accuracy (target registration error, 0.82 ± 0.37mm). The mean dose-length product (DLP) of the scout and registration scan was 243.16 ± 392.34 mGy*cm. Patients 1–16 and 29–39 received a registration scan following the scout scan, whereas patients 17–28 received a registration scan without a prior scout scan. The effective radiation dose of the registration CT scans (patients 17–28) and scout scans (patients 1–16 and 29–39) was 0.58 ± 1.05 mSv.
In 13 patients (patients numbered 1, 2, 5, 6, 7, 8, 9, 10, 11, 15, 16, 17 and 20) a control iCT scan for exclusion of perioperative complications and control of the extent of resection was performed. Repeat iCT scanning was used for updating navigation.
Augmented reality: The major indications to select a patient for surgery using the AR application were invasive tumors with encasement of the carotid and medial cerebral arteries, all tumors with close relation to the optic chiasm, giant tumors (tumor volume > 10 cm3) or recurrent tumors. Accuracy of patient registration and microscope registration were the two dependent variables for clinical AR accuracy. Microscope registration accuracy was checked by applying the AR visualization of the reference array outline. Landmark checks were successfully performed, apart from checking the target registration error (TRE), which confirmed high accuracy and excluded errors due to potential shift (Figure 2).
AR improved orientation in the surgical field for all patients as it reliably visualized the structures of interest and closely matched them to the visualized objects and the visible tumor outline. This was particularly useful in giant tumors with encasement and displacement of the cerebral arteries and compression of the optic chiasm (patients 4, 6, 8, 9, 10, 12, 13, 14, 18, 20, 22, 27, 31, 32, 33 and 36) as well as in cases of recurrent tumors (patients 24 and 35). No injuries to critical neurovascular structures occurred. The tumor was visualized in all patients, followed by vessels of interest (27 patients or 62.3%) and the optic chiasm and optic nerves in 22 patients, or 56.4%. Individual objects or HUDs could be switched off on the preference of the surgeon, in the case of AR information overflow. If this was the case, further AR support was provided by the standard navigation display and AR display on the video screens, which allowed the assisting staff to monitor the surgery, thereby serving as an educational tool.

Illustrative Cases

Case 1: Patient no. 28 was a 77-year-old female patient with right clinoidal meningioma who experienced visual field deficits and visual deterioration. A complete resection of the tumor was performed via right fronto-temporal craniotomy. AR support facilitated the course of the resection with prompt localization of the segmented carotid and cerebral arteries, as well as the optic chiasm, providing surgical precision throughout the procedure. Figure 3 demonstrates navigation and AR support at the beginning of the tumor resection and Figure 4 shows the microscopic view following the gross total resection of the tumor. The patient recovered fully and was neurologically intact. Operative video has been added to Supplementary Materials: Video Pt 28.
Case 2: A 38-year-old female patient with giant medial sphenoid wing meningioma on the left side presented with vertigo (patient number 9). GTR was performed using iCT-based navigation registration and microscope-based AR. Figure 5 demonstrates the intraoperative view throughout the resection and Figure 6 shows preoperative and postoperative MRI imaging. The patient recovered fully and had no neurological deficits. Operative video has been added to the Supplemental Materials: Patient number 9.
Case 3: A 67-year-old female patient (patient number 19) with visual deterioration and bitemporal hemianopsia. MRI showed a suprasellar meningioma which was resected via right pterional approach. Figure 7 demonstrates the visualization of the structures in the AR throughout the surgery.
Case 4: The patient was a 55-year-old male with multiple intracranial meningiomas (patient no. 31). He underwent two surgeries and radiotherapy for lateral sphenoid wing meningioma on the left side. Due to tumor progression, he underwent subtotal resection (Simpson Grade III) via left fronto-temporal approach. Histology indicated an atypical meningioma WHO II°, and postoperative particle radiation therapy (carbon protons) was performed. The operative video demonstrates the surgical resection of the tumor using microscope-based AR (Supplementary Materials: Pt 31).
Case 5: A 72-year-old patient presented in a comatose state following several days of mental symptoms (patient number 36). He underwent GTR for WHO I° olfactory meningioma via bifrontal approach. Following surgery, the patient experienced prolonged weaning followed by tracheotomy. Furthermore, a hydrocephalus developed, and a subduro-peritoneal shunt was implanted. The patient recovered to an extent that allowed him to walk; however, assistance in everyday life is necessary.
Clinical outcome: An overview of clinical characteristics of the patients is provided in Table 2.
Only one patient deteriorated postoperatively, with a new CN III palsy (patient no. 7). CN III palsy in this patient improved during the postoperative course. Eight patients improved following surgery and thirty patients remained unchanged. Perioperative surgical complications occurred in six patients (15.4%) and included cerebrospinal fluid (CSF) leaks which required surgical interventions (patients no. 4 and 23), wound healing deficits which prompted wound revision (patient no. 9), as well as postoperative hydrocephalus with implantations of a ventriculoperitoneal (patient no. 28) and subduro-peritoneal shunt (patient no. 36). Patient no. 20, with giant olfactory meningioma, experienced a massive pulmonary embolism five days following surgery, which caused asystolia, cardiopulmonary reanimation and diffuse brain swelling due to hypoxia. She underwent bifrontal craniectomy and subsequent ventriculoperitoneal shunt implantation. This patient, unfortunately, remained having an apallic syndrome.
Further non-operative complications included heart failure due to asystolia with cardiopulmonary reanimation (patient no. 11), a pulmonary embolism which required cardiopulmonary reanimation (patient no. 14), pneumonia (patient no. 16) and sinus venous thrombosis with a pulmonary embolism (patient no. 29). These four patients recovered fully.
The mean follow-up time was 26.7 ± 21 months. Four patients died before follow-up. Patient no. 8 died eleven days after surgery due to septic shock caused by pancolitis. Patient no. 18 died three months following surgery due to a pulmonary embolism. Patients no. 26 and 34 underwent surgery for skull base lesions suspected of brain metastases; however, the histology has shown a diagnosis of WHO I° meningioma. Patient no. 26 died 7 months following surgery due to progression of a renal cell carcinoma, and patient no. 34, died 3 months following surgery due to progression of liver failure caused by metastases of malignant melanoma.
Patients numbered 1–4, 16, 13, 14, 16, 22, 30, 31, 32, 35 and 39 underwent postoperative particle radiotherapy. Indications for radiotherapy were Simpson Grade III, IV and V resections, tumors with invasion of the cavernous sinus or a WHO II° histology. The average time range from surgery to radiotherapy was 5.62 ± 1.94 months. Tumor recurrence and progression occurred in four patients (patients no. 2, 3, 16 and 31). Patient no. 2 experienced recurrence 60 months following surgery and was proposed surgical treatment, but refused further therapy. Patient no. 3 underwent two further surgeries due to the tumor’s progression (30 months and 55 months following primary surgery) and subsequent irradiation. Patient no. 16 was followed up with due to asymptomatic progression, which occurred 6 months following radiation therapy. Patient no. 31 experienced a tumor progress in the setting of meningiomatosis and WHO II° histology 16 months following surgery. This patient underwent a re-radiation for tumor progression. At the follow-up, 33 out of 35 patients could ambulate at their last presentation.

4. Discussion

A skull base location, WHO II° and higher pathology grades, together with a subtotal resection, are independent predictors of unfavorable outcomes in meningiomas [20]. Compared to non-skull base meningiomas, patients with skull base meningiomas have more frequent neurological deficits and impairment of these deficits following surgery, less GTR and shortened retreatment free survival, which does not affect overall survival [16]. As shown here, the use of neuronavigation and AR could assist in improved orientation in the surgical field and lead to less adverse advents and injury to neurovascular structures, possibly increasing the rate of the extent of resection. The issue of brain shift and the subsequent need for intraoperative image updating is less problematic in skull base lesions due to the small extent of intraoperative shift of the tumor and vessels because of their attachment to the bony structures of the skull base [1]. In our study, 67% of patients underwent GTR of the tumor. This is comparable to the current data in the literature on series of resections of skull base meningiomas. A study on 1148 consecutive patients demonstrated that GTRs are less frequent in skull base compared to non-skull base meningiomas (62% vs. 84%) [16]. However, skull base meningiomas include several types of tumors at different locations; thus, the extent of resection in conjunction with surgical and clinical outcomes may vary. Surgical management has further evolved from classical surgery to surgery with standard use of advanced imaging and neuronavigation, use of preoperative embolization in selected cases, radiotherapy and radiosurgery, as well as drug therapy, genetic profiling and oncologic management [21]. Treatment objectives consist of GTR wherever possible, with preservation of patients’ functions, quality of life and independence in daily living as the postoperative goal (Karnofsky performance score KPS > 70%). If GTR is not possible due to a high risk of endangering patients’ functions and quality of life, adjuvant treatment is mandatory [21]. Therefore, the optimal treatments for certain types of skull base meningiomas have evolved. It has become common in the clinical practice to perform subtotal or partial resection of the cavernous sinus meningiomas, following irradiation of the residuals [21]. The trend of aggressive resection of cavernous sinus and other skull base meningiomas has declined since the 1980s and 1990s, with contemporary series showing GTR rates of 53%, complication rates of 17.9% and 0.9% and adjuvant treatment rates of 22.2% [21]. A study by De Maio et al., in a series of 117 patients with skull base meningiomas, reported that 90.3% of patients had a KPS > 80% at follow-up [21].
Despite the evolution of different treatment options for skull base meningioma, the most possible, safest extent of resection still plays a central role in the therapy. AR can greatly enhance the safety of the resection, improving the orientation in the operative field and early identification of critical structures. Spatial accuracy of preoperative image segmentation with intraoperative data for skull base surgery has already been investigated [1]. The surgeon is not challenged to merge the neuronavigation data with the operative field by himself/herself, with AR performing this task instead, which is advantageous compared to traditional neuronavigation [6]. In the current literature only three cases of AR use for skull base meningiomas have been reported [11,12,13]. Use of microscope-based AR has shown to be reassuring, particularly for less experienced surgeons [1]. Whereas bony and neurovascular landmarks present reliable navigational tools for experienced surgeons, these landmarks are not fixed in all cases; thus, the use of 3D segmentation and AR can detect anatomical variations [1]. Neurovascular structures which are often invaded or displaced by skull base tumors can be visualized on MRIs, segmented and superimposed on the microscope in real-time fashion, which enables identification of these structures and is considered to be the decisive advantage in the resection of these lesions [1]. Although various devices have been used to achieve AR, including smartphones, tablets and head-mounted devices [22], microscope-based AR is currently the best way to apply AR due to an obligation to use the microscope for skull base surgery.
When clear anatomical landmarks are lacking, for example, in cases of large destructive skull base tumors and reoperations, AR can decisively assist in comprehending the 3D surgical anatomy and improve the comfort, precision and intraoperative orientation of the surgeon [5]. Standards to assess the quality of AR visualization in neurosurgery are not well established [11] and thus far rely on the subjective impression of the surgeon. A recent study on utilization of AR in cranial surgery of 55 cases reported that 66.7% of surgeons found AR visualization helpful in individual cases with acceptable accuracy and depth information [11]. Furthermore, in cases of large tumors with encasement of the cerebral vessels, using AR during resection provides a good orientation and depth-in perception to the localization of the vessels inside the tumor, which reduces the risk of damaging these structures. Even if positional shift occurs, such as movement of the registration array, the size of the object remains displayed correctly. This facilitates the estimation of the extent of tumor resections [5].
Monitoring of the AR clinical accuracy can be achieved by evaluating intraoperatively anatomical landmarks that can be clearly located on the pre- or intraoperative images [7]. Using visible bony structures of the skull base that can be superimposed with a semitransparent display of a bony reconstruction of the CT data to adjust navigation, fine tuning of AR navigation can be performed [7]. The 3D display of AR objects provided intuitive depth perception and a very close match with the visible extent of the tumor, vessels and optic nerves, and its AR representation was observed. The possibility to switch on and off each object can eliminate the information overflow by AR objects [5]. AR usage in relation to microscope time varies between 44% (11) and 51% [5].
In order to rely on AR to perform surgery close to neurovascular risk structures, it is mandatory to have a high navigation accuracy. Patient registration using user-independent intraoperative imaging-based methods is highly recommended [7]. The main use of intraoperative CT imaging for cranial procedures has been found to be in skull base and neurovascular surgery, where resection is the most effective therapy for preservation of the recovery of visual function, especially in skull base tumors of orbital structures, paraorbital structures and optic nerves [23]. The use of neuronavigation was recommended earlier in skull base surgery as the normal anatomy is often distorted, leading to a higher risk of misidentification of anatomic landmarks and resulting in potential functional damage of neural structures [24]. In skull base surgery, the problem of brain shift does not pose a crucial obstacle for the use of AR and neuronavigation based on solid bony structures which can be used for navigation updates and checks. Due to integration of neuronavigation into the operative workflow, its use has become standard for skull base surgery in neuro- and ear, throat and nose (ENT) surgery [25].
Thus far, there are several studies that examined the role of neuronavigation and intraoperative imaging in the resection of skull base lesions [4,7,8,23,24,26,27,28]. Recent studies reported that use of navigation led to decreased recurrence rate, blood loss and length of hospitalization, and improved recurrence-free-survival and performance status in resections of meningiomas [29,30]. The main indication for iCT in cranial surgery is registration scanning [4]. An iCT-based neuronavigation allows referencing in the same patient position in which the surgery is performed. This leads to elimination of position-dependent brain shift and improves navigation accuracy [24]. A drawback of iCT-based automatic registration is that the patient is exposed to radiation [27]. Low-dose protocols allowed for significant reduction of the ED (effective dose). Thus, iCT can be routinely applied due to precise depiction of bony landmarks and high neuronavigation accuracy. Furthermore, a negligible brain shift in the region of the skull base and a short duration of examination even enables repeated iCT scans if needed, without significantly prolonging the surgery time [24]. Intraoperative control of resection with a second control scan as a standard procedure for all skull base operations is not necessary, yet it can be helpful in a highly selected cohort of patients where the extent of resection is affected by distorted anatomy and the involvement of osseous structures that need to be checked intraoperatively [24]. Recent studies on orbit-associated tumors, most of them being meningiomas, showed that intraoperative imaging caused the change in surgical approach and strategy, due to an unexpected residual tumor or additional tumor that was initially not visualized because of the overlay of osseous tumor parts [24]. In our study, control iCT scans were performed to exclude perioperative complications and for estimation of the extent of resection. However, no complications occurred and the surgical strategy was not changed according to the control iCT.
Future directions may include surgical rehearsals with AR-templates for complex skull base cases. A recent video article on the resection of clinoid meningioma demonstrated the use of surgical rehearsal in virtual reality (VR) with an AR-template, where the author demonstrated how AR-enhanced navigation was used for the planning of the incision and soft-tissue exposure and for the guiding of the drilling of the sphenoid wing and the extradural clinoidectomy [13]. Use of VR and AR-templates according to an individualized patient’s anatomy could cause a paradigm shift where the surgeon at the surgery duplicates the plan which he/she has already rehearsed [13]. This application would also be an excellent educational tool for residents and less experienced surgeons and an important addition—but not a complete substitution—to traditional skull base surgery training in a cadaver laboratory.
There are several limitations of this study. This is a single surgeon retrospective study, which makes its results and conclusions only partially reproducible. However, prospective studies with the use of AR, including its use in the educational setting with less experienced surgeons and the possibility of presurgical rehearsal with AR-templates, are needed to objectively evaluate the use of AR for resection of skull base meningiomas. In our study, follow-up time was too short to make adequate conclusions on the course of the disease, yet our primary goal was to demonstrate the use of AR for the surgical resection, whereas further follow-up is needed for assessment of the long-term outcomes. Since the AR was switched off in cases of information overflow, the microscopic-based AR did not always provide support throughout the entire procedure. There is no control group with patients who underwent resection without use of iCT-based navigation and AR. However, a control group of patients who would undergo surgery without optimal conditions is considered unethical and unpractical.

5. Conclusions

A microscope-based AR facilitated surgical orientation for resection of skull base meningiomas. Registration accuracy was very high using automatic registration with intraoperative imaging. AR proved to be very useful in cases of large skull base meningiomas which encase cerebral vessels through early identification of risk structures and in cases of tumors which compressed the optic chiasm and optic nerves, as well as in reoperations. Enhanced understanding of 3D anatomy could be of potential use as an educational tool and assistance for less experienced surgeons.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/cancers14092302/s1, operative videos: Patient number 9, Pt 28, Pt 31, Pt 36.

Author Contributions

Conceptualization, M.P. and C.N.; methodology, M.P.; software, M.P.; validation, M.P., M.H.A.B., B.S., B.C. and C.N.; formal analysis, M.P.; investigation, M.P.; resources, M.P. and C.N.; data curation, M.P.; writing—original draft preparation, M.P.; writing—review and editing, M.P., M.H.A.B., B.S., B.C. and C.N.; visualization, M.P.; supervision, C.N.; project administration, M.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The authors obtained ethics approval for prospective archiving of clinical and technical data applying intraoperative imaging and navigation (study no. 99/18) from the local ethics committee at the University Hospital Marburg.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data in this study are available on request from the corresponding authors.

Acknowledgments

The authors thank J.W. Bartsch for proofreading the manuscript.

Conflicts of Interest

All authors certify that they have no affiliations with, or involvement in, any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript, with the exception that B. Carl and Ch. Nimsky received a speaker honorarium from Brainlab. Both Ch. Nimsky and M. Bopp serve as scientific consultants for Brainlab.

References

  1. Dolati, P.; Gokoglu, A.; Eichberg, D.; Zamani, A.; Golby, A.; Al-Mefty, O. Multimodal navigated skull base tumor resection using image-based vascular and cranial nerve segmentation: A prospective pilot study. Surg. Neurol. Int. 2015, 6, 172. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Rachinger, J.; Von Keller, B.; Ganslandt, O.; Fahlbusch, R.; Nimsky, C. Application Accuracy of Automatic Registration in Frameless Stereotaxy. Stereotact. Funct. Neurosurg. 2006, 84, 109–117. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Eggers, G.; Kress, B.; Mühling, J. Fully Automated Registration of Intraoperative Computed Tomography Image Data for Image-Guided Craniofacial Surgery. J. Oral Maxillofac. Surg. 2008, 66, 1754–1760. [Google Scholar] [CrossRef]
  4. Carl, B.; Bopp, M.; Saß, B.; Nimsky, C. Intraoperative computed tomography as reliable navigation registration device in 200 cranial procedures. Acta Neurochir. 2018, 160, 1681–1689. [Google Scholar] [CrossRef] [PubMed]
  5. Carl, B.; Bopp, M.; Saß, B.; Pojskic, M.; Nimsky, C. Augmented reality in intradural spinal tumor surgery. Acta Neurochir. 2019, 161, 2181–2193. [Google Scholar] [CrossRef]
  6. Cabrilo, I.; Sarrafzadeh, A.; Bijlenga, P.; Landis, B.; Schaller, K. Augmented reality-assisted skull base surgery. Neurochirurgie 2014, 60, 304–306. [Google Scholar] [CrossRef]
  7. Carl, B.; Bopp, M.; Voellger, B.; Saß, B.; Nimsky, C. Augmented Reality in Transsphenoidal Surgery. World Neurosurg. 2019, 125, e873–e883. [Google Scholar] [CrossRef]
  8. Lai, M.; Skyrman, S.; Shan, C.; Babic, D.; Homan, R.; Edström, E.; Persson, O.; Burström, G.; Elmi-Terander, A.; Hendriks, B.H.; et al. Fusion of augmented reality imaging with the endoscopic view for endonasal skull base surgery; a novel application for surgical navigation based on intraoperative cone beam computed tomography and optical tracking. PLoS ONE 2020, 15, e0227312. [Google Scholar]
  9. Pennacchietti, V.; Stoelzel, K.; Tietze, A.; Lankes, E.; Schaumann, A.; Uecker, F.C.; Thomale, U.W. First experience with augmented reality neuronavigation in endoscopic assisted midline skull base pathologies in children. Child’s Nerv. Syst. 2021, 37, 1525–1534. [Google Scholar] [CrossRef]
  10. Creighton, F.X.; Unberath, M.; Song, T.; Zhao, Z.; Armand, M.; Carey, J. Early Feasibility Studies of Augmented Reality Navigation for Lateral Skull Base Surgery. Otol. Neurotol. 2020, 41, 883–888. [Google Scholar] [CrossRef]
  11. Roethe, A.L.; Rösler, J.; Misch, M.; Vajkoczy, P.; Picht, T. Augmented reality visualization in brain lesions: A prospective randomized controlled evaluation of its potential and current limitations in navigated microneurosurgery. Acta Neurochir. 2021, 164, 3–14. [Google Scholar] [CrossRef] [PubMed]
  12. Lavé, A.; Meling, T.R.; Schaller, K.; Corniola, M.V. Augmented reality in intracranial meningioma surgery: Report of a case and systematic review. J. Neurosurg. Sci. 2020, 64, 369–376. [Google Scholar] [CrossRef] [PubMed]
  13. Jean, W.C. Mini-Pterional Craniotomy and Extradural Clinoidectomy for Clinoid Meningioma: Optimization of Exposure Using Augmented Reality Template: 2-Dimensional Operative Video. Oper. Neurosurg. 2020, 19, E610. [Google Scholar] [CrossRef] [PubMed]
  14. McDermott, M.W.; Ohata, K.; Benes, V. Introduction. Skull base meningioma treatment strategies. Neurosurg. Focus 2018, 44, E1. [Google Scholar] [CrossRef] [PubMed]
  15. Magill, S.T.; Ore, C.L.D.; Diaz, M.A.; Jalili, D.D.; Raleigh, D.R.; Aghi, M.K.; Theodosopoulos, P.V.; McDermott, M.W. Surgical outcomes after reoperation for recurrent non–skull base meningiomas. J. Neurosurg. 2018, 131, 1179–1187. [Google Scholar] [CrossRef] [Green Version]
  16. Meling, T.R.; Da Broi, M.; Scheie, D.; Helseth, E. Meningiomas: Skull base versus non-skull base. Neurosurg. Rev. 2018, 42, 163–173. [Google Scholar] [CrossRef]
  17. DeMonte, F.; McDermott, M.W.; Al-Mefty, O. Al-Mefty’s Meningiomas; Thieme Medical Publishers Inc.: New York, NY, USA, 2011. [Google Scholar]
  18. Simpson, D. The Recurrence of intracranial meningiomas after surgical treatment. J. Neurol. Neurosurg. Psychiatry 1957, 20, 22–39. [Google Scholar] [CrossRef] [Green Version]
  19. Combs, S.E.; Edler, L.; Burkholder, I.; Rieken, S.; Habermehl, D.; Jäkel, O.; Haberer, T.; Unterberg, A.; Wick, W.; Debus, J.; et al. Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial. BMC Cancer 2010, 10, 615. [Google Scholar] [CrossRef] [Green Version]
  20. Savardekar, A.R.; Patra, D.P.; Bir, S.; Thakur, J.D.; Mohammed, N.; Bollam, P.; Georgescu, M.-M.; Nanda, A. Differential Tumor Progression Patterns in Skull Base Versus Non–Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature. World Neurosurg. 2018, 112, e74–e83. [Google Scholar] [CrossRef]
  21. Di Maio, S.; Ramanathan, D.; Garcia-Lopez, R.; Rocha, M.H.; Guerrero, F.P.; Ferreira, M., Jr.; Sekhar, L.N. Evolution and future of skull base surgery: The paradigm of skull base meningiomas. World Neurosurg. 2012, 78, 260–275. [Google Scholar] [CrossRef]
  22. Cho, J.; Rahimpour, S.; Cutler, A.; Goodwin, C.R.; Lad, S.P.; Codd, P. Enhancing Reality: A Systematic Review of Augmented Reality in Neuronavigation and Education. World Neurosurg. 2020, 139, 186–195. [Google Scholar] [CrossRef] [PubMed]
  23. Schichor, C.; Terpolilli, N.; Thorsteinsdottir, J.; Tonn, J.-C. Intraoperative Computed Tomography in Cranial Neurosurgery. Neurosurg. Clin. N. Am. 2017, 28, 595–602. [Google Scholar] [CrossRef] [PubMed]
  24. Terpolilli, N.A.; Rachinger, W.; Kunz, M.; Thon, N.; Flatz, W.H.; Tonn, J.-C.; Schichor, C. Orbit-associated tumors: Navigation and control of resection using intraoperative computed tomography. J. Neurosurg. 2016, 124, 1319–1327. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Wirtz, C.R. Intraoperative navigation, with focus on the skull base. HNO 2016, 64, 635–640. [Google Scholar] [CrossRef]
  26. Marcus, H.; Schwindack, C.; Santarius, T.; Mannion, R.; Kirollos, R. Image-guided resection of spheno-orbital skull-base meningiomas with predominant intraosseous component. Acta Neurochir. 2013, 155, 981–988. [Google Scholar] [CrossRef]
  27. Carl, B.; Bopp, M.; Saß, B.; Pojskic, M.; Gjorgjevski, M.; Voellger, B.; Nimsky, C. Reliable navigation registration in cranial and spine surgery based on intraoperative computed tomography. Neurosurg. Focus 2019, 47, E11. [Google Scholar] [CrossRef] [Green Version]
  28. Watanabe, K.; Zomorodi, A.R.; Labidi, M.; Satoh, S.; Froelich, S.; Fukushima, T. Visualization of Dark Side of Skull Base with Surgical Navigation and Endoscopic Assistance: Extended Petrous Rhomboid and Rhomboid with Maxillary Nerve–Mandibular Nerve Vidian Corridor. World Neurosurg. 2019, 129, e134–e145. [Google Scholar] [CrossRef]
  29. Bir, S.C.; Konar, S.K.; Maiti, T.K.; Thakur, J.D.; Guthikonda, B.; Nanda, A. Utility of Neuronavigation in Intracranial Meningioma Resection: A Single-Center Retrospective Study. World Neurosurg. 2016, 90, 546–555.e1. [Google Scholar] [CrossRef]
  30. Narayan, V.; Bir, S.C.; Mohammed, N.; Savardekar, A.R.; Patra, D.P.; Nanda, A. Surgical Management of Giant Intracranial Meningioma: Operative Nuances, Challenges, and Outcome. World Neurosurg. 2018, 110, e32–e41. [Google Scholar] [CrossRef]
Figure 1. Preoperative planning and image fusion for 67-year-old female patient with suprasellar meningioma (patient no. 19). (A) Visualization of the tumor (ochre), optic nerves and tract (orange) and optic chiasms (yellow) as a 3D object following segmentation in T1-weighted post-contrast magnetic resonance imaging (MRI) and time-of-flight (TOF) MRI angiography. (B) Rigid fusion of computed tomography scan with T1-weighted MRI scan.
Figure 1. Preoperative planning and image fusion for 67-year-old female patient with suprasellar meningioma (patient no. 19). (A) Visualization of the tumor (ochre), optic nerves and tract (orange) and optic chiasms (yellow) as a 3D object following segmentation in T1-weighted post-contrast magnetic resonance imaging (MRI) and time-of-flight (TOF) MRI angiography. (B) Rigid fusion of computed tomography scan with T1-weighted MRI scan.
Cancers 14 02302 g001
Figure 2. AR accuracy check. Patient no. 21 underwent a resection for suprasellar meningioma via right pterional approach. (A) Microscope video with focus on the tumor following exposure, with (A1) T1-weighted post-contrast MRI axial view of standard navigation display with segmented objects (tumor, optic chiasm and nerves in yellow and carotid arteries in violet). Focus of the microscope is shown as seen on the standard navigation display. (B) Microscope video with head-up display and 3-dimensional (3D) visualization of the segmented objects during the resection, with focus on right optic nerve, which shows high accuracy with the intraoperative situation. (B1) T1-weighted post-contrast MRI axial view of navigation, with focus on right optic nerve. (C) Microscope video with head-up display and 3D visualization of tumor outline, optic nerve and ipsilateral carotid artery following tumor resection with focus on the skull base with (C1) T1-weighted post-contrast MRI axial view of navigation. (D) Same as in C, microscope focus is on the contralateral carotid artery; segmented tumor outline and the course of the contralateral optic nerve are visualized with (D1) T1-weighted post-contrast MRI axial view of navigation, which shows focus of the microscope as seen on the standard navigation screen.
Figure 2. AR accuracy check. Patient no. 21 underwent a resection for suprasellar meningioma via right pterional approach. (A) Microscope video with focus on the tumor following exposure, with (A1) T1-weighted post-contrast MRI axial view of standard navigation display with segmented objects (tumor, optic chiasm and nerves in yellow and carotid arteries in violet). Focus of the microscope is shown as seen on the standard navigation display. (B) Microscope video with head-up display and 3-dimensional (3D) visualization of the segmented objects during the resection, with focus on right optic nerve, which shows high accuracy with the intraoperative situation. (B1) T1-weighted post-contrast MRI axial view of navigation, with focus on right optic nerve. (C) Microscope video with head-up display and 3D visualization of tumor outline, optic nerve and ipsilateral carotid artery following tumor resection with focus on the skull base with (C1) T1-weighted post-contrast MRI axial view of navigation. (D) Same as in C, microscope focus is on the contralateral carotid artery; segmented tumor outline and the course of the contralateral optic nerve are visualized with (D1) T1-weighted post-contrast MRI axial view of navigation, which shows focus of the microscope as seen on the standard navigation screen.
Cancers 14 02302 g002
Figure 3. Navigation and AR support during surgery (patient no. 28). (A) Microscope video with head-up display and 3-dimensional (3D) visualization of the segmented objects (tumor in yellow, carotid and anterior cerebral arteries in blue, optic chiasm in yellow). (B,C) Probe’s eye view in 2D and 3D mode. Navigation display in (D) axial, (E) coronal and (F) sagittal view with the segmented objects (focus on the tumor following debulking). (G) AR display on video screen with the 3D outline of tumor, carotid arteries, optic nerves and chiasm. (H) Corresponding probe’s eye view. (I) Target view (tumor and further objects outside of the focus plane are visualized) and (J) video plane in relation to the 3D objects.
Figure 3. Navigation and AR support during surgery (patient no. 28). (A) Microscope video with head-up display and 3-dimensional (3D) visualization of the segmented objects (tumor in yellow, carotid and anterior cerebral arteries in blue, optic chiasm in yellow). (B,C) Probe’s eye view in 2D and 3D mode. Navigation display in (D) axial, (E) coronal and (F) sagittal view with the segmented objects (focus on the tumor following debulking). (G) AR display on video screen with the 3D outline of tumor, carotid arteries, optic nerves and chiasm. (H) Corresponding probe’s eye view. (I) Target view (tumor and further objects outside of the focus plane are visualized) and (J) video plane in relation to the 3D objects.
Cancers 14 02302 g003
Figure 4. Navigation and AR support following complete resection of the tumor (patient no. 20). (A) Microscope video with head-up display and 3-dimensional (3D) visualization of the segmented objects (tumor in yellow, carotid and anterior cerebral arteries in blue, optic chiasm in yellow). (B,C) Probe’s eye view in 2-dimensional and 3D fashion. (D) Axial, (E) coronal and (F) sagittal views of standard navigation display with the segmented objects (focus on the sellar floor following complete resection). (G) AR display on video screen with the 3D outline of segmented structures. (H) Corresponding probe’s eye view. (I) Target view and (J) overview depicting the video plane in relation to the segmented 3D objects.
Figure 4. Navigation and AR support following complete resection of the tumor (patient no. 20). (A) Microscope video with head-up display and 3-dimensional (3D) visualization of the segmented objects (tumor in yellow, carotid and anterior cerebral arteries in blue, optic chiasm in yellow). (B,C) Probe’s eye view in 2-dimensional and 3D fashion. (D) Axial, (E) coronal and (F) sagittal views of standard navigation display with the segmented objects (focus on the sellar floor following complete resection). (G) AR display on video screen with the 3D outline of segmented structures. (H) Corresponding probe’s eye view. (I) Target view and (J) overview depicting the video plane in relation to the segmented 3D objects.
Cancers 14 02302 g004
Figure 5. Navigation and AR support following complete resection of the tumor (patient no. 9). (A) Microscope video with head-up display and 3-dimensional (3D) visualization of the segmented objects (tumor in yellow, carotid, anterior and media cerebral arteries in red) following craniotomy. (B,C) Probe’s eye view in 2D and 3D fashion. (D) Axial, (E) coronal and (F) sagittal views of standard navigation display with the segmented objects. (G) Microscope video during the resection at the point where carotid artery in cavernous sinus is reached with (H,I) probe’s eye view in 2D and 3D fashion with AR objects on the screen. (J) Axial, (K) coronal and (L) sagittal views of standard navigation display with the segmented objects.
Figure 5. Navigation and AR support following complete resection of the tumor (patient no. 9). (A) Microscope video with head-up display and 3-dimensional (3D) visualization of the segmented objects (tumor in yellow, carotid, anterior and media cerebral arteries in red) following craniotomy. (B,C) Probe’s eye view in 2D and 3D fashion. (D) Axial, (E) coronal and (F) sagittal views of standard navigation display with the segmented objects. (G) Microscope video during the resection at the point where carotid artery in cavernous sinus is reached with (H,I) probe’s eye view in 2D and 3D fashion with AR objects on the screen. (J) Axial, (K) coronal and (L) sagittal views of standard navigation display with the segmented objects.
Cancers 14 02302 g005
Figure 6. Preoperative axial (A) and coronal (B) T1-weighted post-contrast MRI of the head in patient number 9 shows a large medial sphenoid wing meningioma with encasement of carotid and cerebral medial artery. Postoperative axial (C) and coronal (D) postcontrast MRI of the head shows complete resection of the tumor.
Figure 6. Preoperative axial (A) and coronal (B) T1-weighted post-contrast MRI of the head in patient number 9 shows a large medial sphenoid wing meningioma with encasement of carotid and cerebral medial artery. Postoperative axial (C) and coronal (D) postcontrast MRI of the head shows complete resection of the tumor.
Cancers 14 02302 g006
Figure 7. Navigation and augmented reality support during surgery (patient no. 19, same patient as in Figure 1). (A) Three-dimensional visualization of the segmented objects as seen through the microscope video with head up display (tumor in yellow, optic chiasm and optic nerves in orange), showing navigation update after craniotomy with focus on Sylvian fissure in (A1) axial and (A2) coronal view of the standard navigation. (B) Three-dimensional visualization of segmented objects (with vessels in red) following retraction of the frontal lobe with (B1) corresponding probe’s eye view, (B2) target view and (B3) overview depicting the video plane in relation to the segmented objects in 3D fashion. (C) Microscope video of tumor exposure with head-up display with (C1) corresponding probe’s eye view, (C2) target view and (C3) overview of the video plane. (D) AR display on video screen with the 3D outline of tumor, carotid arteries, optic nerves and chiasm with focus on the carotid artery, following complete resection of the tumor with (D1) probe’s eye view, (D2) target view and (D3) overview of the video plane.
Figure 7. Navigation and augmented reality support during surgery (patient no. 19, same patient as in Figure 1). (A) Three-dimensional visualization of the segmented objects as seen through the microscope video with head up display (tumor in yellow, optic chiasm and optic nerves in orange), showing navigation update after craniotomy with focus on Sylvian fissure in (A1) axial and (A2) coronal view of the standard navigation. (B) Three-dimensional visualization of segmented objects (with vessels in red) following retraction of the frontal lobe with (B1) corresponding probe’s eye view, (B2) target view and (B3) overview depicting the video plane in relation to the segmented objects in 3D fashion. (C) Microscope video of tumor exposure with head-up display with (C1) corresponding probe’s eye view, (C2) target view and (C3) overview of the video plane. (D) AR display on video screen with the 3D outline of tumor, carotid arteries, optic nerves and chiasm with focus on the carotid artery, following complete resection of the tumor with (D1) probe’s eye view, (D2) target view and (D3) overview of the video plane.
Cancers 14 02302 g007
Table 1. General characteristics of the cohort.
Table 1. General characteristics of the cohort.
No.SexAge (Years)Location of the TumorExtent of ResectionSimpson GradeTumor Volume (cm3)Visualized Objects in AR
1m57Cavernous sinus/petroclival rightPRIV11Tumor, Vessels
2f64Clinoidal leftGTRII13.4Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts, Ventricles
3m55Cavernous sinus rightOpen BiopsyV3.3Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
4m67Anterior fossa/planum sphenoidaleGTRII53Tumor
5m80Olfactory meningiomaGTRI14.3Tumor, Chiasm, Optic Nerves, Optic Tracts, Ventricles, Cerebrum
6f50Middle and posterior fossa/petrous leftPRIV68.8Tumor
7m65Medial sphenoid wing meningioma leftGTRII15.8Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
8f89Anterior fossa/planum sphenoidaleSTRIV44.2Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
9f38Medial sphenoid wing leftGTRII39.2Tumor, Vessels
10m81Lateral sphenoid wing rightGTRII64.6Tumor, Vessels
11f76Olfactory meningiomaGTRI10.7Tumor, Chiasm, Optic Nerves, Optic Tracts
12f76Olfactory meningiomaGTRII60.4Tumor
13m48Lateral sphenoid wing leftSTRIII98.2Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
14f558Cavernous sinus leftPRV62.1Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
15f83Clinoidal meningioma rightGTRII3.18Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
16f80Planum sphenoidaleSTRIV3.47Tumor
17m46Olfactory meningiomaGTRII5.91Tumor
18f51Anterior fossa/planum sphenoidaleGTRII53.4Tumor, Vessels
19f67Suprasellar meningiomaGTRI8.45Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts, Pituitary Gland
20f50Anterior fossa/falxGTRII109Tumor, Vessels
21f71Suprasellar meningiomaGTRII1.32Tumor, Vessels, Chiasm, Optic Nerves
22m82Cavernous sinus rightSTRIII26.7Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
23f82Suprasellar meningiomaGTRII6.05Tumor, Vessels, Bone, Chiasm, Optic Nerves, Optic Tracts
24m71Recurrent clinoidal meningioma rightSTRIII0.54Tumor, Vessels, Bone, Chiasm, Optic Nerves, Optic Tracts, Ventricles, Cerebrum
25f60Olfactory meningiomaGTRI1.66Tumor
26f68Medial sphenoid wing rightGTRII1.28Tumor
27f54Lateral sphenoid wing rightGTRII20.6Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
28f77Clinoidal meningioma rightGTRI8.43Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
29f67Cavernous sinus meningioma leftPRV11Tumor, Vessels
30f71Clinoidal meningioma rightGTRI3.34Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
31m55Recurrent lateral sphenoid wing leftSTRIV24.8Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
32f41Lateral sphenoid wing rightSTRIV29.8Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
33m64Medial sphenoid wing rightGTRII28.2Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
34f70Clinoidal meningioma rightGTRI2.92Tumor, Chiasm, Optic Nerves, Optic Tracts
35f47Recurrent medial sphenoid wing rightPRIV7.12Tumor, Vessels
36m72Olfactory meningiomaGTRI68.9Tumor, Vessels
37f71Anterior fossa/planum sphenoidaleGTRII1.4Tumor
38f52Cavernous sinus/temporobasal meningioma leftGTRII1.8Tumor
39f45Suprasellar meningioma rightGTRII1.91Tumor, Vessels, Chiasm, Optic Nerves, Optic Tracts
Table 2. Clinical characteristics of the patient cohort.
Table 2. Clinical characteristics of the patient cohort.
No.SymptomsNeurological Deficits Prior to SurgeryNeurological Deficits Following Surgery
1Incidental following mild TBINoneNone
2Visual symptomsVisual deterioration (Visus R 0.3, L 0.7)Improved vision (Visus R 0.5, L 1.0)
3CNVI palsyCNVI palsyCNVI palsy
4TremorTremorNone
5Anosmia, headacheAnosmiaAnosmia
6HeadacheNoneNone
7SeizureNoneCNIII palsy
8Blindness right eyeBlindness right eyeUnchanged
9VertigoNoneNone
10Double visionNoneNone
11HeadacheAnosmiaAnosmia
12Gait difficulties, anosmiaAnosmiaAnosmia
13Visual symptomsVisual deteriorationNone
14Visual symptomsCNIII palsyCN III palsy
15Visual symptomsVisual deterioration (R 0.2, L 0.7)Improved vision (R 0.2, L 0.8)
16Visual symptomsVisual deterioration (R 0.1, L 0.4)Improved vision (R 0.2, L 0.3)
17SeizureNoneNone
18SeizureNoneNone
19Visual symptomsVisual det (R 0.7, L 0.8), bitemp. hemianopsiaImproved vision (R 0.7, L 0.9)
20HydrocephalusNoneNone
21Hypesthesia in right upper extremityNoneNone
22SeizureNoneNone
23CNIV palsyCNIV palsyCN IV palsy
24Visual symptomsVisual deterioration (L 0.16)Improved vision (L 0.2)
25Incidental findingNoneNone
26Screening due to renal carcinomaNoneNone
27DepressionNoneNone
28Visual symptomsVisual field deficits RNone
29CN IV palsyCN IV palsyCN IV palsy
30DepressionNoneNone
31None- MRI follow-up following prior surgeryCN IV palsy, CN III palsyCN IV and CN III palsy
32Visual symptomsVisual deterioration (R 0.6, L 1)Improved vision (R 1.0)
33Visual symptoms, dementiaVisual deterioration (R 0.2, L 0.05)Unchanged vision (R 0.2, L 0.05)
34Visual symptomsVisual deterioration (R 0.7)Unchanged vision (R 0.7)
35None- MRI follow-up following prior surgeryNoneNone
36ComaAnosmiaAnosmia
37HeadacheNoneNone
38Cognitive problemsNoneNone
39HeadacheNoneNone
Table legend: CN—cranial nerve, R—right eye, L—left eye, TBI—traumatic brain injury.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pojskić, M.; Bopp, M.H.A.; Saβ, B.; Carl, B.; Nimsky, C. Microscope-Based Augmented Reality with Intraoperative Computed Tomography-Based Navigation for Resection of Skull Base Meningiomas in Consecutive Series of 39 Patients. Cancers 2022, 14, 2302. https://doi.org/10.3390/cancers14092302

AMA Style

Pojskić M, Bopp MHA, Saβ B, Carl B, Nimsky C. Microscope-Based Augmented Reality with Intraoperative Computed Tomography-Based Navigation for Resection of Skull Base Meningiomas in Consecutive Series of 39 Patients. Cancers. 2022; 14(9):2302. https://doi.org/10.3390/cancers14092302

Chicago/Turabian Style

Pojskić, Mirza, Miriam H. A. Bopp, Benjamin Saβ, Barbara Carl, and Christopher Nimsky. 2022. "Microscope-Based Augmented Reality with Intraoperative Computed Tomography-Based Navigation for Resection of Skull Base Meningiomas in Consecutive Series of 39 Patients" Cancers 14, no. 9: 2302. https://doi.org/10.3390/cancers14092302

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop